Protocol No.: S1914

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Principal Investigator
Pollock, Jondavid
Phase
II
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institution
Wheeling Hospital
Contacts
Jeanne Fuscardo, RN, OCN
Research Coordinator
Phone: +1 304-243-3490
Maher Kali, MD
Clinical Research Specialist
Phone: +1 304-243-7045

View on ClinicalTrials.gov